ARCTURUS THERAPEUTICS Trademark

Trademark Overview

On Friday, March 13, 2015, a trademark application was filed for ARCTURUS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ARCTURUS THERAPEUTICS trademark a serial number of 86563776. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, February 16, 2024. This trademark is owned by Arcturus Therapeutics, Inc.. The ARCTURUS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for RNA medicines comprising small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutic agents to enable the targeting of any gene in the human genome

Scientific and medical research
arcturus therapeutics

General Information

Serial Number86563776
Word MarkARCTURUS THERAPEUTICS
Filing DateFriday, March 13, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, February 16, 2024
Registration Number5443638
Registration DateTuesday, April 10, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, a lipid-enabled drug delivery system for RNA medicines comprising small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutic agents to enable the targeting of any gene in the human genome
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesScientific and medical research

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 25, 2015
Primary Code005
First Use Anywhere DateMonday, February 8, 2016
First Use In Commerce DateMonday, February 8, 2016
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 25, 2015
Primary Code042
First Use Anywhere DateFriday, November 30, 2012
First Use In Commerce DateFriday, November 30, 2012

Trademark Owner History

Party NameArcturus Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameArcturus Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameArcturus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, February 16, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, February 16, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 15, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 29, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, April 10, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 10, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, March 8, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 7, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 6, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, February 12, 2018USE AMENDMENT FILED
Wednesday, February 28, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 12, 2018TEAS STATEMENT OF USE RECEIVED
Saturday, September 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 31, 2017SOU EXTENSION 3 GRANTED
Thursday, August 31, 2017SOU EXTENSION 3 FILED
Thursday, August 31, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, March 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 9, 2017SOU EXTENSION 2 GRANTED
Thursday, March 9, 2017SOU EXTENSION 2 FILED
Thursday, March 9, 2017SOU TEAS EXTENSION RECEIVED
Thursday, September 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2016SOU EXTENSION 1 GRANTED
Tuesday, September 6, 2016SOU EXTENSION 1 FILED
Tuesday, September 6, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, March 15, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2016PUBLISHED FOR OPPOSITION
Wednesday, December 30, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 12, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 10, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 7, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 7, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 24, 2015NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, June 24, 2015EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, June 24, 2015COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Wednesday, June 24, 2015EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, June 17, 2015ASSIGNED TO EXAMINER
Wednesday, March 25, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 17, 2015NEW APPLICATION ENTERED

Related Keywords

therapeutics arcturus enable targeting agents oligotherapeutic microrna gene human research medical scientific